"Anti-malarial Drugs Market Adverse effects and Choosing a Drug to Prevent Malaria"

Malaria is common infectious disease caused by the protozoan parasite, Plasmodium parasites. The bite of an infected female Anopheles mosquito transmits a parasite to the person’s body, which then enters into the person’s liver where the production of parasite occurs. Human malaria are generally caused by five types of plasmodium parasites, including P. falciparum, P. malariae, P. ovale, P. vivax, and P.knowlesi. Among these, P. falciparum and P. vivax are the most dangerous species of parasite causing highest number of malaria mortality. Early diagnosis and efficient treatment are crucial measures to control malaria. Different types of drugs such as quinine, chloroquine, mefloquine, proguanil, primaquine, and others are used in the treatment of malaria. Moreover, some combination drugs such as Pyrimethamine & sulfadoxine, Artemether & lumefantrine, and others are also prescribed for treating the disease. According to the World Health Organization (WHO), around 91 countries and territories are at the risk of malaria transmission.

Request Sample Copy with TOC, Graphs & List of Figures @ https://www.coherentmarketinsights.com/insight/request-sample/3726

The increasing number of regulatory approvals and launches of anti-malaria drugs is expected to propel growth of the global anti-malarial drugs market over the forecast period. For instance, in July 2018, GSK and Medicines for Malaria Venture (MMV) received the U.S. FDA approval for Krintafel (tafenoquine), a first single dose medicine to prevent the relapse of P. vivax malaria marks. Moreover, in July 2017, Cipla and Medicines for Malaria Venture (MMV) launched Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a drug used for the treatment of severe malaria in young children.

Launching of anti-malaria drugs in the malaria affected areas such as African countries such as Uganda and other South-east Asian countries is expected to drive growth of the anti-malarial drugs market. For instance, in April 2019, Shin Poong Pharmaceutical Co.Ltd, South Korea, and Medicines for Malaria Venture (MMV) launched Pyramax, an anti-malarial drug combination of pyronardine and artesunate, in Uganada. Moreover, in December 2014, Ranbaxy Laboratories Limited launched Synriam, a new anti-malarial drug, in 7 African countries including Nigeria, Uganda, Senegal, Cameroon, Guinea, Kenya, and Ivory Coast. Moreover, in April 2012, the drug was approved by the Drug Controller General of India (DCGI) for marketing in India.

The report provides a detailed analysis of the major market players along with an overview of their business, expansion plans, and strategies. The main actors examined in the report include: Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, and Roche Inc.

By Drug Class:

Aminoquinolines
Quinoline-methanol (4-quinolinemethanols)
Cinchona Alkaloids
Biguanides
Sulfonamides and sulfones
Others
By Route of Administration:

Oral
Injectable
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Get | PDF Brochure of this Report@
https://www.coherentmarketinsights.com/insight/request-pdf/3726

Table of Contents

Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Mergers and Acquisitions
Pipeline Analysis
Regulatory Scenario
Reimbursement Scenario
PEST Analysis
Global Anti-malarial Drugs Market, By Drug Class, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Aminoquinolines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Quinoline-methanol (4-quinolinemethanols)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Cinchona Alkaloids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Biguanides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million) Corticosteroids
Sulfonamides and sulfones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Anti-malarial Drugs Market, By Route of Administration, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)

Global Anti-malarial Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Anti-malarial Drugs Market, By Region, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, By Region, 2019 and 2027 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2027
Regional Trends
North America
Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
GCC
Israel
Rest of Middle East

Exclusive offer!!! Purchase the report at a discounted rate!!!
Flat Instant discount of US$ 2000

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/3726

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.